Sign Out
RhTPO therapy should be given under direct medical supervision. The administration, dose and course of treatment should be adjusted according to the different disease. The following administration is recommended: when patient receives chemotherapy on malignant solid tumor, the dosage of drug may lead to thrombocytopenia and bleeding, then rhTPO shall be given by SC injection in 6-24 hrs after chemotherapy. The dose is 300 units/kg bodyweight once everyday by SC administration continually for 14 days.
The administration shall be stopped when the level of platelet return to be higher than 100 x 109/L. Anemia or leukopenia associated with chemotherapy, rhTPO shall be used respectively in combination with rhG-CSF or rhEPO.
Continue with Google